Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy

11 Feb 2016

Abstract excerpt

// Pragya Srivastava 1 , Benjamin E. Paluch 2 , Junko Matsuzaki 3 , Smitha R. James 2 , Golda Collamat-Lai 2 , Nadja Blagitko-Dorfs 4 , Laurie Ann Ford 1 , Rafeh Naqash 1 , Michael Lübbert 4 , Adam R. Karpf 5 , Michael J. Nemeth 1,6 and Elizabeth A. Griffiths 1,2,6 1 Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA 2 Department of Pharmacology and Therapeutics, Roswell Park Cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Immune Cell Function and Interaction
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26883197
DOI: 10.18632/oncotarget.7326

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapyPMID 26883197Read ↗

Cancer‐testis antigen expression and its epigenetic modulation in acute myeloid leukemiaSemantic proximity Read ↗

Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotype.Semantic proximity Read ↗

Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cellsSemantic proximity Read ↗

Effects of Hypomethylating Agents on Gene Modulation in the Leukemic Microenvironment and Disease Trajectory in a Mouse Model of AMLSemantic proximity Read ↗

Human Leukocyte Antigen (HLA) Peptides Derived from Tumor Antigens Induced by Inhibition of DNA Methylation for Development of Drug-facilitated ImmunotherapySemantic proximity Read ↗

The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulationSemantic proximity Read ↗

Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen‐specific cellular immunitySemantic proximity Read ↗

Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancersSemantic proximity Read ↗

Autophagy degrades immunogenic endogenous retroelements induced by 5-azacytidine in acute myeloid leukemiaSemantic proximity Read ↗

Mechanisms of Action of Hypomethylating Agents: Endogenous Retroelements at the EpicenterSemantic proximity Read ↗

Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?Semantic proximity Read ↗

Effective Treatment with Venetoclax and Hypomethylating Agents for the Coexistence of Multiple Myeloma and Acute Myeloid Leukemia: A Case Report and Literature Review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.